Share on

Middle East & Africa Preimplantation Genetic Testing Market Research Report - Segmented By Procedure Type, Technology, Products & Services, Application, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2023 to 2028)

Published: March, 2023
ID: 6677
Pages: 145
Formats: report pdf report excel report power bi report ppt

MEA Preimplantation Genetic Testing Market Size & Growth (2023 to 2028):

As per the research report, the size of the Middle East and Africa Preimplantation Genetic Testing Market is valued at USD 29.01 million in 2023 and estimated to be growing at a CAGR of 10.30%, to reach USD 47.37 million by 2028 during the forecast period 2023 to 2028.

Preimplantation genetic detection is a method that examines the embryos that are creating using the process of in vitro fertilization. This facilitates the implantation of only selected fit embryos into the uterus thus making sure that a healthy baby is delivered. This prevents the carrying of genetic disorders into the family generations. The testing is done by a screening process wherein the healthy ones are frozen and stored.

The increasing occurrence of infertility around the world, growing support from public and private organizations in this field, rising medical facilities catering to patients with fertility issues, advancing technology in the field of genetics, awareness about chromosomal anomalies with the growing age of mother are all the factors that can be attributed to the growth of the preimplantation genetic testing market.

This research report on the MEA Preimplantation Genetic Testing Market has been segmented and sub-segmented into the following categories:

By Procedure Type:

  • Genetic Diagnosis
  • Genetic Screening

By Technology:

  • NGS
  • PCR
  • FISH
  • CGH
  • SNP

By Products & Services:

  • Reagents And Consumables
  • Instruments
  • Software And Services

By Application:

  • Structural Chromosomal Abnormalities
  • Single Gene Disorders
  • X-Linked Disorders
  • HLA Typing
  • Gender Identification

By End User:

  • Fertility Clinics
  • Hospitals
  • Research Laboratories

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Developing countries in this region are likely to push forward the growth of the Middle East and Africa Preimplantation Genetic Testing market.

The leading companies leading in the MEA Preimplantation Genetic Testing Market profiled in the report are Illumina, Inc., Yikon Genomics, CooperSurgical, Oxford Gene Technology, Inc., Thermo Fisher Scientific, Inc., Rubicon Genomics, Inc., Agilent Technologies, Inc., Natera, Inc., Abbott Laboratories, PerkinElmer, Inc., and SciGene Corporation.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample